GoodRx: David Becomes Goliath

DjelicS/E+ via Getty Images
Investment Thesis
After GoodRx (GDRX) announced strong, expanding growth in all three segments of their business, shares popped nearly 14%. GoodRx also updated Q3 guidance, which topped Wall Street estimates. As seen in their…

Click here to view the original article.